Patents by Inventor Shuihong GAO

Shuihong GAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230071112
    Abstract: The present invention relates to linkers having a group of propioloyl, substituted acryl (acryloyl), or disubstituted propanoyl, and using such linkers for the conjugation of compounds, in particular, cytotoxic agents to a cell-binding molecule.
    Type: Application
    Filed: June 8, 2022
    Publication date: March 9, 2023
    Applicant: Hangzhou DAC Biotech Co., Ltd.
    Inventors: Yongxin Robert ZHAO, Qingliang YANG, Yuanyuan HUANG, Shun GAI, Hangbo YE, Linyao ZHAO, Chengyu YANG, Huihui GUO, Xiaomai ZHOU, Hongsheng XIE, Haifeng ZHU, Yifang XU, Qianqian TONG, Junxiang JIA, Minjun CAO, Wenjun LI, Shuihong GAO, Zhixiang GUO, Lu BAI, Chen LI, Yanlei YANG, Chunyan WANG, Zhichang YE
  • Publication number: 20230001001
    Abstract: A conjugation of a cytotoxic drug to a cell-binding molecule with a bis-linker (dual-linker) as shown in Formula (I). Bis-linkage methods of making a conjugate of a cytotoxic drug/molecule to a cell-binding agent in a specific manner are also described, as well as application of the conjugates for the treatment of a cancer, or an autoimmune disease, or an infectious disease. wherein “” is an optional bond; X, Y, Z1, and Z2 are a functional group; m1 and n are a integer; L1 and L2 are a linker.
    Type: Application
    Filed: July 30, 2021
    Publication date: January 5, 2023
    Applicant: Hangzhou DAC Biotech Co., Ltd.
    Inventors: Robert Yongxin ZHAO, Yuanyuan HUANG, Qingliang YANG, Shun GAI, Hangbo YE, Linyao ZHAO, Chengyu YANG, Yifang XU, Huihui GUO, Minjun CHAO, Qianqian TONG, Wenjun LI, Xiang CAI, Xiaomai ZHOU, Hongsheng XIE, Junxiang JIA, Haifeng ZHU, Zhixiang GUO, Shuihong GAO, Chunyan WANG, Chen LIN, Yanlei YANG, Zhicang YE, Jie PENG, Jun XU, Xiaotao ZUO, Qingyu SU
  • Publication number: 20220323602
    Abstract: The present invention relates to linkers having a group of propiolyl, substituted acryl (acryloyl), or disubstituted propanoyl, and using such linkers for the conjugation of compounds, in particular, cytotoxic agents to a cell-binding molecule.
    Type: Application
    Filed: June 8, 2022
    Publication date: October 13, 2022
    Applicant: Hangzhou DAC Biotech Co., Ltd.
    Inventors: Yongxin Robert ZHAO, Qingliang YANG, Yuanyuan HUANG, Shun GAI, Hangbo YE, Linyao ZHAO, Chengyu YANG, Huihui GUO, Xiaomai ZHOU, Hongsheng XIE, Haifeng ZHU, Yifang XU, Qianqian TONG, Junxiang JIA, Minjun CAO, Wenjun LI, Shuihong GAO, Zhixiang GUO, Lu BAI, Chen LI, Yanlei YANG, Chunyan WANG, Zhichang YE
  • Publication number: 20220313837
    Abstract: The present invention relates to linkers having a group of propiolyl, substituted acryl (acryloyl), or disubstituted propanoyl, and using such linkers for the conjugation of compounds, in particular, cytotoxic agents to a cell-binding molecule.
    Type: Application
    Filed: June 8, 2022
    Publication date: October 6, 2022
    Applicant: Hangzhou DAC Biotech Co., Ltd.
    Inventors: Yongxin Robert ZHAO, Qingliang YANG, Yuanyuan HUANG, Shun GAI, Hangbo YE, Linyao ZHAO, Chengyu YANG, Huihui GUO, Xiaomai ZHOU, Hongsheng XIE, Haifeng ZHU, Yifang XU, Qianqian TONG, Junxiang JIA, Minjun CAO, Wenjun LI, Shuihong GAO, Zhixiang GUO, Lu BAI, Chen LI, Yanlei YANG, Chunyan WANG, Zhichang YE
  • Publication number: 20220313836
    Abstract: The present invention relates to linkers having a group of propiolyl, substituted acryl (acryloyl), or disubstituted propanoyl, and using such linkers for the conjugation of compounds, in particular, cytotoxic agents to a cell-binding molecule.
    Type: Application
    Filed: June 8, 2022
    Publication date: October 6, 2022
    Applicant: Hangzhou DAC Biotech Co., Ltd.
    Inventors: Yongxin Robert ZHAO, Qingliang YANG, Yuanyuan HUANG, Shun GAI, Hangbo YE, Linyao ZHAO, Chengyu YANG, Huihui GUO, Xiaomai ZHOU, Hongsheng XIE, Haifeng ZHU, Yifang XU, Qianqian TONG, Junxiang JIA, Minjun CAO, Wenjun LI, Shuihong GAO, Zhixiang GUO, Lu BAI, Chen LI, Yanlei YANG, Chunyan WANG, Zhichang YE
  • Publication number: 20220313838
    Abstract: The present invention relates to linkers having a group of propiolyl, substituted acryl (acryloyl), or disubstituted propanoyl, and using such linkers for the conjugation of compounds, in particular, cytotoxic agents to a cell-binding molecule.
    Type: Application
    Filed: June 8, 2022
    Publication date: October 6, 2022
    Applicant: Hangzhou DAC Biotech Co., Ltd.
    Inventors: Yongxin Robert ZHAO, Qingliang YANG, Yuanyuan HUANG, Shun GAI, Hangbo YE, Linyao ZHAO, Chengyu YANG, Huihui GUO, Xiaomai ZHOU, Hongsheng XIE, Haifeng ZHU, Yifang XU, Qianqian TONG, Junxiang JIA, Minjun CAO, Wenjun LI, Shuihong GAO, Zhixiang GUO, Lu BAI, Chen LI, Yanlei YANG, Chunyan WANG, Zhichang YE
  • Publication number: 20210393790
    Abstract: A conjugation of a cytotoxic drug to a cell-binding molecule with a bis-linker (dual-linker) as shown in Formula (I). Bis-linkage methods of making a conjugate of a cytotoxic drug/molecule to a cell-binding agent in a specific manner are also described, as well as application of the conjugates for the treatment of a cancer, or an autoimmune disease, or an infectious disease. wherein “” is an optional bond; X, Y, Z1, and Z2 are a functional group; m1 and n are a integer; L1 and L2 are a linker.
    Type: Application
    Filed: July 30, 2021
    Publication date: December 23, 2021
    Applicant: Hangzhou DAC Biotech Co., Ltd.
    Inventors: Robert Yongxin ZHAO, Yuanyuan HUANG, Qingliang YANG, Shun GAI, Hangbo YE, Linyao ZHAO, Chengyu YANG, Yifang XU, Huihui GUO, Minjun CHAO, Qianqian TONG, Wenjun LI, Xiang CAI, Xiaomai ZHOU, Hongsheng XIE, Junxiang JIA, Haifeng ZHU, Zhixiang GUO, Shuihong GAO, Chunyan WANG, Chen LIN, Yanlei YANG, Zhicang YE, Jie PENG, Jun XU, Xiaotao ZUO, Qingyu SU
  • Publication number: 20210369855
    Abstract: A conjugation of a cytotoxic drug to a cell-binding molecule with a bis-linker (dual-linker) as shown in Formula (I). Bis-linkage methods of making a conjugate of a cytotoxic drug/molecule to a cell-binding agent in a specific manner are also described, as well as application of the conjugates for the treatment of a cancer, or an autoimmune disease, or an infectious disease. wherein “” is an optional bond; X, Y, Z1, and Z2 are a functional group; m1 and n are a integer; L1 and L2 are a linker.
    Type: Application
    Filed: July 28, 2021
    Publication date: December 2, 2021
    Applicant: Hangzhou DAC Biotech Co., Ltd.
    Inventors: Robert Yongxin ZHAO, Yuanyuan HUANG, Qingliang YANG, Shun GAI, Hangbo YE, Linyao ZHAO, Chengyu YANG, Yifang XU, Huihui GUO, Minjun CHAO, Qianqian TONG, Wenjun LI, Xiang CAI, Xiaomai ZHOU, Hongsheng XIE, Junxiang JIA, Haifeng ZHU, Zhixiang GUO, Shuihong GAO, Chunyan WANG, Chen LIN, Yanlei YANG, Zhicang YE, Jie PENG, Jun XU, Xiaotao ZUO, Qingyu SU
  • Publication number: 20210308277
    Abstract: The present invention relates to linkers having a group of propiolyl, substituted acryl(acryloyl), or disubstituted propanoyl, and using such linkers for the conjugation of compounds, in particular, cytotoxic agents to a cell-binding molecule.
    Type: Application
    Filed: November 14, 2016
    Publication date: October 7, 2021
    Applicant: Hangzhou DAC Biotech Co., Ltd.
    Inventors: Yongxin Robert Zhao, Qingliang Yang, Yuanyuan Huang, Shun Gai, Hangbo Ye, Linyao Zhao, Chengyu Yang, Huihui Guo, Xiaomai Zhou, Hongsheng Xie, Haifeng Zhu, Yifang Xu, Qianqian Tong, Junxiang Jia, Minjun Cao, Wenjun Li, Shuihong Gao, Zhixiang Guo, Lu Bai, Chen LI, Yanlei YANG, Chunyan WANG, Zhichang YE
  • Publication number: 20200069814
    Abstract: A conjugation of a cytotoxic drug to a cell-binding molecule with a bis-linker (dual-linker) as shown in Formula (I). Bis-linkage methods of making a conjugate of a cytotoxic drug/molecule to a cell-binding agent in a specific manner are also described, as well as application of the conjugates for the treatment of a cancer, or an autoimmune disease, or an infectious disease. wherein “” is an optional bond; X, Y, Z1, and Z2 are a functional group; m1 and n are a integer; L1 and L2 are a linker.
    Type: Application
    Filed: April 6, 2017
    Publication date: March 5, 2020
    Applicant: Hangzhou DAC Biotech Co., Ltd.
    Inventors: Robert Yongxin ZHAO, Yuanyuan HUANG, Qingliang YANG, Shun GAI, Hangbo YE, Linyao ZHAO, Chengyu YANG, Yifang XU, Huihui GUO, Minjun CHAO, Qianqian TONG, Wenjun LI, Xiang CAI, Xiaomai ZHOU, Hongsheng XIE, Junxiang JIA, Haifeng ZHU, Zhixiang GUO, Shuihong GAO, Chunyan WANG, Chen LIN, Yanlei YANG, Zhicang YE, Jie PENG, Jun XU, Xiaotao ZUO, Qingyu SU